<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02184923</url>
  </required_header>
  <id_info>
    <org_study_id>verticality_percept_stroke_zrh</org_study_id>
    <nct_id>NCT02184923</nct_id>
  </id_info>
  <brief_title>Verticality Perception in Stroke Patients</brief_title>
  <official_title>Verticality Perception in Patients With Acute Lateralized Lesions Along the Central Graviceptive Pathways- Acute Assessment on the Ward and the Stroke Center</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Zurich</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Zurich</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The long-term goal of this research is to advance our knowledge of how information from the
      labyrinth is brought to perception and how adaptation to vestibular imbalance influences
      spatial orientation. In healthy human subjects verticality perception is accurate while
      upright.The strategy of this research is to quantify changes in verticality perception after
      unilateral lesions along the central graviceptive pathways and to assess the frequency and
      pattern of abnormal verticality perception in patients with acute stroke (ischemic or
      hemorrhagic). Our underlying hypothesis is that screening for erroneous verticality
      perception by use of a mobile device assessing the subjective visual vertical (SVV) during
      the acute phase (i.e., within 24-48 hours after symptom onset) reliably identifies those
      patients with defects. Early detection of deficits in verticality perception may help to
      initiate balance physiotherapy early.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2014</start_date>
  <completion_date type="Anticipated">August 2019</completion_date>
  <primary_completion_date type="Anticipated">March 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy of verticality perception</measure>
    <time_frame>during the measurement period (10 minutes)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Test-re-test reliability of verticality perception</measure>
    <time_frame>from session 1 (day 0) to session 2 (day 1)</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Verticality Perception in Stroke</condition>
  <arm_group>
    <arm_group_label>verticality measurements</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>presentation of visual vertical</intervention_name>
    <arm_group_label>verticality measurements</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. ages 18-90 years

          2. informed consent

          3. for group 1: acute (i.e. symptom onset &lt;3 days ago) lateralized ischemia or hemorrhage
             as confirmed by clinical examination and / or brain imaging (CT or MRI).

          4. absence of exclusion criteria

        Exclusion Criteria:

          1. history of a peripheral-vestibular deficit

          2. disturbed consciousness

          3. severe sensory or motor aphasia

          4. visual field deficits

          5. other neurological or systemic disorder which can cause dementia or cognitive
             dysfunction

          6. intake of antidepressants, sedatives, or neuroleptics
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dominik Straumann, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital Zurich, Division of Neurology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alexander Tarnutzer, MD</last_name>
    <phone>41442555653</phone>
    <email>alexander.tarnutzer@usz.ch</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Zurich</name>
      <address>
        <city>Zurich</city>
        <state>ZH</state>
        <zip>8091</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alexander Tarnutzer, MD</last_name>
      <phone>41442555653</phone>
      <email>alexander.tarnutzer@usz.ch</email>
    </contact>
    <investigator>
      <last_name>Alexander Tarnutzer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Susanne Wegener, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aneta Drakul</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dominik Straumann, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Zwergal A, Rettinger N, Frenzel C, Dieterich M, Brandt T, Strupp M. A bucket of static vestibular function. Neurology. 2009 May 12;72(19):1689-92. doi: 10.1212/WNL.0b013e3181a55ecf.</citation>
    <PMID>19433743</PMID>
  </reference>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 3, 2014</study_first_submitted>
  <study_first_submitted_qc>July 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 9, 2014</study_first_posted>
  <last_update_submitted>October 25, 2016</last_update_submitted>
  <last_update_submitted_qc>October 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

